First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
value - The stock trades at 0.2x sales and generates 4.6% FCF yield, attracting value investors seeking stable cash flows in defensive…
Rising interest rates increase financing costs on the $29B debt load (4.15x leverage)…
Watch on earnings: Generic drug deflation rates (Rx price index) impacting gross profit dollars per unit distributed, Specialty pharmaceutical market growth rates, particularly oncology and immunology therapeutic areas, Federal funds rate and 10-year Treasury yield affecting debt service costs on $29B debt load.
One Sentence Summary:
Cencora: the story is balanced — specialty pharmaceutical revenue growth rates, particularly oncology and biosimilar distribution volumes.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.